Why UK Patients Compare Wegovy vs Mounjaro Dosing Schedules
Wegovy Dosing vs Mounjaro: Fundamental Mechanism Differences
Understanding Wegovy dosing compared to Mounjaro starts with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, while Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors simultaneously. This dual-receptor approach in Mounjaro may influence how patients respond to different dosing schedules. Wegovy dosing follows a methodical escalation: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and finally 2.4mg maintenance from week 17 onwards.
Mounjaro's dosing schedule spans six dose levels from 2.5mg to 15mg, typically starting at 2.5mg and increasing every four weeks based on tolerability and clinical response. The higher numerical doses reflect tirzepatide's different molecular structure rather than increased potency. Both medications require prescription-only access and clinical assessment, but their dosing philosophies differ significantly in escalation timing and maintenance strategies.
Wegovy Dosing Costs vs Mounjaro Pricing at EverydayMeds
Wegovy dosing costs vary across the five-dose escalation schedule, with transparent pricing at every stage. The 0.25mg starter dose costs £79.99, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Our Intro Duo bundle combines 0.25mg and 0.5mg doses for £169.99, providing your first two months of Wegovy dosing in one convenient order.
Mounjaro pricing follows a different structure reflecting its unique dosing requirements, starting from £89.99 for the 2.5mg initial dose. When comparing total monthly costs during maintenance phases, both medications represent significant investments in long-term weight management. However, Wegovy dosing may offer more predictable monthly budgeting once you reach the 2.4mg maintenance phase, while Mounjaro costs can vary depending on your optimal maintenance dose level.
Clinical Evidence Behind Wegovy Dosing Schedules
Wegovy dosing protocols were established through the landmark STEP clinical trial programme, particularly STEP 1 which demonstrated approximately 15% average weight loss at 68 weeks when used alongside a reduced-calorie diet and increased physical activity. The gradual dose escalation in Wegovy dosing helps minimise gastrointestinal side effects while optimising therapeutic response. Wilding et al., NEJM, 2021, documented how the structured dose increases support patient adherence and clinical outcomes.
Mounjaro's dosing strategy emerged from the SURMOUNT trials, showing its own efficacy profile with the dual GIP+GLP-1 mechanism. However, directly comparing weight loss percentages between Wegovy and Mounjaro trials isn't appropriate due to different trial designs, patient populations, and methodologies. What matters most is finding the right dosing approach for your individual circumstances under proper medical supervision.
How Wegovy Dosing Affects Your Body's Response
Wegovy dosing works by activating GLP-1 receptors in your brain's appetite control centres, promoting feelings of fullness after smaller meals and potentially reducing food cravings. The gradual dose escalation allows your body to adapt to semaglutide's effects, starting with the gentle 0.25mg introduction and building to the therapeutic 2.4mg maintenance level. Each dose increase in the Wegovy schedule serves a specific purpose: establishing tolerance, building efficacy, and ultimately achieving sustained appetite regulation. The prescription-only medicine must be used alongside a reduced-calorie diet and increased physical activity to maximise its weight management potential. This structured Wegovy dosing approach helps ensure you receive optimal therapeutic benefits while minimising potential side effects during your weight management journey.
EverydayMeds Wegovy Dosing Assessment and Delivery Process
Accessing Wegovy dosing through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your eligibility and determine the most appropriate starting approach. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), considering your medical history, current medications, and weight management goals. Once approved, your Wegovy dosing schedule begins with next-day delivery via our temperature-controlled cold-chain logistics network. Each FlexTouch pen arrives with comprehensive dosing instructions and ongoing support from our GPhC-registered pharmacy team (#9012878). Our prescribers can adjust your Wegovy dosing timeline if needed, ensuring your treatment remains safe and effective throughout your weight management journey.
Storage and Practical Wegovy Dosing Considerations
Wegovy dosing success depends partly on proper storage and handling of your FlexTouch injection pens. Store unopened pens in your refrigerator at 2-8°C, but once removed, Wegovy can remain at room temperature (below 30°C) for up to 6 weeks – significantly longer than Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy dosing more convenient for travel and daily life flexibility. Each pen contains four doses, administered once weekly on the same day, and the FlexTouch design ensures accurate dosing without online pharmacy preparation. The clear dosing window lets you confirm each injection, supporting adherence to your prescribed Wegovy dosing schedule. Remember to rotate injection sites between your thigh, upper arm, or abdomen to maintain comfort and absorption consistency.
Wegovy Dosing Flexibility vs Mounjaro's Titration Options
One key difference between Wegovy dosing and Mounjaro lies in titration flexibility and maintenance options. Wegovy follows a standardised escalation to 2.4mg maintenance, with limited flexibility for dose adjustments once you reach the therapeutic level. If you experience persistent side effects during Wegovy dosing, your prescriber might extend time at a lower dose rather than increase immediately. Mounjaro offers more titration options with its six available doses, potentially allowing for more personalised dose optimisation based on your response and tolerability profile.
However, this flexibility in Mounjaro dosing can also create uncertainty about optimal long-term dosing, while Wegovy's structured approach provides clearer endpoint expectations. Both medications require ongoing medical supervision, but Wegovy dosing may suit patients who prefer predictable escalation schedules. Your EverydayMeds prescriber can discuss which approach aligns better with your treatment preferences and lifestyle requirements during your clinical assessment.
Making Your Wegovy Dosing Decision with Expert Support
Choosing between Wegovy dosing and Mounjaro isn't a decision you should make alone – it requires careful consideration of your medical history, lifestyle factors, and weight management goals. At EverydayMeds, our clinical team provides balanced guidance on both options without bias toward either prescription-only medicine. We stock both Wegovy and Mounjaro, ensuring you can access whichever option your prescriber recommends as most suitable. Your assessment includes discussion of each medication's dosing schedule, expected timeline to therapeutic effect, and practical considerations like storage and injection technique. Whether you choose Wegovy's structured 5-dose escalation or Mounjaro's flexible 6-dose range, our ongoing clinical support helps optimise your treatment outcomes. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your assessment, apply your discount code at checkout, and start your professionally-supervised weight management journey with confidence.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
